{"accession":"0001628280-26-050134","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-050134/NetCashProvidedByUsedInOperatingActivities","change":0.09786374133949191,"cik":1800,"company":"ABBOTT LABORATORIES","concept":{"label":"Operating cash flow","label_en":"Operating cash flow","label_ko":"\uc601\uc5c5\ud65c\ub3d9 \ud604\uae08\ud750\ub984","period_type":"duration","xbrl_tag":"NetCashProvidedByUsedInOperatingActivities"},"filed_at":"2026-07-28","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/0001628280-26-050134-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-050134","form":"10-Q","id":"0001628280-26-050134/NetCashProvidedByUsedInOperatingActivities","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/abt-20260630.htm#f-373","unit":"USD","value":3803000000.0,"xbrl_fact_id":"f-373"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/abt-20260630.htm#f-374","unit":"USD","value":3464000000.0,"xbrl_fact_id":"f-374"}],"statement":"ABBOTT LABORATORIES (ABT) reported Operating cash flow of USD 3,803,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0001628280-26-050134, filed 2026-07-28).","ticker":"ABT","url":"https://aiswingx.com/n/0001628280-26-050134/NetCashProvidedByUsedInOperatingActivities","verify_url":"https://www.sec.gov/Archives/edgar/data/1800/000162828026050134/abt-20260630.htm#f-373"}
